Vimarsana
Biggest News Aggregation in the World

Action Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Action Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Action Date Today - Breaking & Trending Today

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024 - Vimarsana News

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024

PDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and...

April 2024 Immigration Visa Bulletin Released | Gibney Anthony & Flaherty, LLP - Vimarsana News

April 2024 Immigration Visa Bulletin Released | Gibney Anthony & Flaherty, LLP

The Department of State released the April 2024 Visa Bulletin. USCIS will continue to accept employment-based Adjustment of Status applications based on the Final Action Dates chart....

March 2024 Immigration Visa Bulletin Released | Gibney Anthony & Flaherty, LLP - Vimarsana News

March 2024 Immigration Visa Bulletin Released | Gibney Anthony & Flaherty, LLP

The Department of State released the March 2024 Visa Bulletin. In March, USCIS will accept employment-based Adjustment of Status applications based on the more modest Final Action Dates...

February 2024 Immigration Visa Bulletin Released | Gibney Anthony & Flaherty, LLP - Vimarsana News

February 2024 Immigration Visa Bulletin Released | Gibney Anthony & Flaherty, LLP

The Department of State released the February 2024 Visa Bulletin. All Employment-Based Categories will hold steady for February under Dates for Filing with minor advancement for EB-2...

FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer - Vimarsana News

FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Company's...